Cefoperazone is a recently developed cephalosporin which has an extended antibacterial spectrum including Enterobacteriaceae, many Pseudomonas aeruginosa, gram-negative and gram-positive aerobic cocci and bacilli, and some anaerobic bacteria (10). Results of several in vitro (6, 10, 12) and a limited number of in vivo (5, 7) preliminary studies suggest that cefoperazone is a useful new cephalosporin. Due to its unique spectrum of activity, no currently approved antimicrobial susceptibility disk in the cephalosporin class is reliable for determining cefoperazone disk diffusion susceptibility. Laboratory testing considerations which have been addressed in this study include determination of the most appropriate content of cefoperazone in disks and the appropriate zone diameter breakpoints to be used for disk diffusion microbial susceptibility testing with cefoperazone.
Cefoperazone agar dilution minimal inhibitory concentration (MIC) susceptibility results were compared with zones of inhibition produced by disk diffusion susceptiblity testing. Disks containing 30, 50, 75, and 100 ,ug of cefoperazone were tested for purposes of regression line comparisons and error rate-bounded analysis. Results suggest that if the MIC equivalent of susceptibility is 32 ,ug/ml, either a 50-,ug disk with zone sizes of susceptibility (S) .15 mm and resistance (R) s12 mm or a 75-jg disk with zone sizes of S >17 mm and R s14 mm may be appropriate. If the MIC equivalent of susceptibility is 64 ,ug/ml, this would dictate use of a 75-,ug disk with zone sizes of S .17 mm and R s12 mm. Disks containing either s30 or .100 ,ug of cefoperazone did not adequately discriminate among susceptible and resistant bacterial strains at either the 32-or 64-,ug/ml MIC equivalent.
Cefoperazone is a recently developed cephalosporin which has an extended antibacterial spectrum including Enterobacteriaceae, many Pseudomonas aeruginosa, gram-negative and gram-positive aerobic cocci and bacilli, and some anaerobic bacteria (10) . Results of several in vitro (6, 10, 12) and a limited number of in vivo (5, 7) preliminary studies suggest that cefoperazone is a useful new cephalosporin. Due to its unique spectrum of activity, no currently approved antimicrobial susceptibility disk in the cephalosporin class is reliable for determining cefoperazone disk diffusion susceptibility. Laboratory testing considerations which have been addressed in this study include determination of the most appropriate content of cefoperazone in disks and the appropriate zone diameter breakpoints to be used for disk diffusion microbial susceptibility testing with cefoperazone.
MATERL AND METHODS
Orpnisms. More than 520 bacterial strains were tested ( SusceptibUilty tests. Agar dilution minimal inhibitory concentration (MIC) and disk diffusion susceptibilities were determined concomitantly with a single overnight Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.) culture of each organism as the source of inoculum. Dilution and diffusion tests were performed as described by an international collaborative study (4) and the National Committee for Clinical Laboratory Standards (9), respectively. Cefoperazone (Pfizer, Inc., New York, N.Y.) was obtained as the dry powder and also as commercially prepared disks containing 30, 50, and 75 Fg of antibiotic. For comparative purposes, disks containing 30, 50, 75, and 100 ,ug of cefoperazone were also prepared in our laboratory. For disk preparation, appropriate concentrations of cefoperazone were diluted in sterile distilled water and dispensed in 20.tJ volumes onto blank paper disks (Schleicher & Schuell Co., Keene, N.H.) supported on a wire mesh screen. The disks were allowed to air dry for 2 h at room temperature and then were stored under dessication at -40°C. MuellerHinton agar (BBL Microbiology Systems) of a single lot was used for preparing the petri dishes for MIC agar dilution and the 150-mm petri dishes used in performing disk diffusion studies. Plates for disk diffusion susceptibilities were prepared so as to contain medium at a depth of 4 to 5 mm. Each plate was inoculated with a standardized (0.5 McFarland) broth suspension of organisms. Two plates were prepared for each organism, and the appropriate disks were added so that determinations could be done in duplicate. Zones of inhibition were measured by two independent observers, and the results of the duplicate disks and duplicate readings were averaged and ex-ANTIMICROB. AGENTS CHEMOTHER. Examples of the comparative zone sizes produced with the 30-, 50-, and 75-,ug disks were 8 to 30, 12 to 33, and 14 to 33 mm for the E. coli strains analyzed and 6 to 29, 3 to 31, and 13 to 35 mm for P. aeruginosa strains. Differences in zone diameters were not obvious when comparing results between 75-and 100-pLg cefoperazone-containing disks. The y-intercepts for the regression lines of the 75-and 100-jxg disks were very similar (10. 74 and 10.65, respectively), and the range of zone sizes of E. coli was 14 to 33 mm for both the 75-and the 100-p,g disks. Disks prepared by the manufacturer and those prepared in our laboratory produced similar results. the number of false-resistant isolates to unacceptable levels.
The data in Table 2 suggested that various zone sizes could be considered as breakpoints for a 32-,ug equivalent of susceptibility when using either a 50-or 75-,ug testing disk. With the 50-,ug disk, false susceptibility was minimal (0 to 0.6%) at all possible susceptible breakpoints greater than 14 mm, and false-resistant strains accounted for fewer than 2% of the isolates with a zone diameter breakpoint for the resistant category of -13 mm. If the MIC equivalent of susceptibility were 32 ,ug/ml and a 75-,ug disk were used, a susceptibility zone diameter breakpoint of .17 mm would result in no falsesusceptible organisms. If a resistant breakpoint of <15 mm were used for this disk content-MIC combination, only 1.3% of the organisms would be falsely resistant, while 5% would appear truly resistant.
Consistently small percentages occurred in each of the error rate-bounded categories using a variety of possible indeterminate zone size ranges with either the 75-or 100-,ug disk and a 64-pug/ml equivalent of susceptibility (Table 2) (5) . Based on the composite of pharmacokinetic data, it appears likely that either a 64-or 32-,ug/ml MIC equivalent of susceptibility will be chosen for cefoperazone (Pfizer, Inc., personal communication). With these concentration points, both the 30-and 50-,ug disk regression lines intersect the no-zone of inhibition diameter y-axis (6 mm) within less than one doubling dilution of the 64-,ug/ml MIC equivalent (Fig. 1) . This portends problems for appropriate category discrimination for strains with indeterminant or borderline susceptible MICs. Therefore, based on these regression data, it appears that a 30-tLg disk may be inappropriate for cefoperazone susceptibility testing at either MIC point, while the use of a 50-p.g disk would only be marginal for an MIC equivalent of 64 ,ug/ml.
As noted earlier, the regression data for the 75-and 100-,ug disks are essentially the same. Considering the decrease in additional effect between disk content and zone diameter for the 100-g disk, use of this disk seems inappropriate. The choice of zone diameter breakpoints for the 75-,ug disk is complicated by the fact that the achievable serum concentrations are so high that most organisms are susceptible to cefoperazone. This feature, as well as the broad spectrum of activity of cefoperazone, results in the occurrence of relatively few resistant bacterial isolates. Thus, using a 64-,ug/ml equivalent, only 5% of all isolates have MICs indicating that they are truly resistant.
Wlhave serum levels of cefoperazone, one must be able to differentiate, within the MIC ranges, those zone measurements which correlate with patient serum levels of 16 to 32 ,g/ml. This is -iot possible with the 30-,ug disk. However, tme must not, through loading the disk excessively, create inflated zone diameters for the resistantrange MICs. It would appear that appropriate values result from either the 50-or 75-pg disk, with some margin of safety present as well.
As noted by Barry (2), the error rate-bounded procedure proposed by Metzler and DeHaan (8) finds its greatest value in establishing zone size interpretive standards for scatter diagrams which do not permit regression analysis. However, this procedure also provides a useful confirmation of our regression data. This analysis confirms the observation that the 30-pg disk would be useful only if the MIC equivalent of susceptibility were to be as low as 16 ,ug/ml. If the MIC equivalent of susceptibility is either 32 or 64 ,g/ml, the zone size breakpoints giving acceptable numbers of false-susceptible and false-resistant strains are too small (S .13 mm, R c8 mh) to warrant consideratioh (Table 2) .
If the MIC equivalent of susceptibity were to be as low as 32 pg/ml, use of a 50-pg disk might be appropriate. 
